Challenge of developing new tuberculosis vaccines to generate life-long protective immunity

References

• Verver S, Warren RM, Beyers N et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care. Med.171, 1430–1435 (2005).
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol.17, 326–332 (2005).
   PubMed Web of Science ®Google Scholar
• Ryan AA, Nambiar JK, Wozniak TM et al. Antigen load governs the differential priming of CD8 T cells in response to the BCG vaccine or Mycobacterium tuberculosis infection. J. Immunol.182, 7172–7177 (2009).
   PubMed Web of Science ®Google Scholar
• Billeskov R, Vingsbo-Lundberg C, Andersen P, Dietrich J. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol.179, 3973–3981 (2007).
   PubMed Web of Science ®Google Scholar
• Fine PE. BCG: the challenge continues. Scand. J. Infect. Dis.33, 243–245 (2001).
   PubMed Web of Science ®Google Scholar
• Mollenkopf HJ, Kursar M, Kaufmann SH. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette–Guérin induce equal protection. J. Infect. Dis.190, 588–597 (2004).
   PubMed Web of Science ®Google Scholar
• Pinto R, Saunders BM, Camacho LR, Britton WJ, Gicquel B, Triccas JA. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette–Guérin vaccine. J. Infect. Dis.189, 105–112 (2004).
   PubMed Web of Science ®Google Scholar
• Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung. Dis.2, 2000–2007 (1998).
   Google Scholar
• Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet348, 17–24 (1996).
   PubMed Web of Science ®Google Scholar
• McShane H, Pathan AA, Sander CR et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med.10, 1240–1244 (2004).
   PubMed Web of Science ®Google Scholar
• Hoft DF. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet372, 164–175 (2008).
   PubMed Web of Science ®Google Scholar
• Ramirez JC, Gherardi MM, Esteban M. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol.74, 923–933 (2000).
   PubMed Web of Science ®Google Scholar
• Halbert CL, Miller AD. AAV-mediated gene transfer to mouse lungs. Methods Mol. Biol.246, 201–212 (2004).
   PubMedGoogle Scholar
• Ryan AA, Wozniak TM, Shklovskaya E et al. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette–Guérin secreting murine GM-CSF is associated with expansion and activation of APCs. J. Immunol.179, 8418–8424 (2007).
   PubMed Web of Science ®Google Scholar
• Tang C, Yamada H, Shibata K et al. Efficacy of recombinant bacille Calmette–Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. J. Infect. Dis.197, 1263–1274 (2008).
   PubMed Web of Science ®Google Scholar
• Grode L, Seiler P, Baumann S et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette–Guérin mutants that secrete listeriolysin. J. Clin. Invest.115, 2472–2479 (2005).
   PubMed Web of Science ®Google Scholar
• Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med.15, 267–276 (2009).
   PubMed Web of Science ®Google Scholar
• Lozza L, Rivino L, Guarda G et al. The strength of T cell stimulation determines IL-7 responsiveness, secondary expansion, and lineage commitment of primed human CD4+IL-7Rhi T cells. Eur. J. Immunol.38, 30–39 (2008).
   PubMed Web of Science ®Google Scholar
• Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol.46, 709–717 (2002).
   PubMed Web of Science ®Google Scholar
• Pym AS, Brodin P, Majlessi L et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med.9, 533–539 (2003).
   PubMed Web of Science ®Google Scholar
• Gonzalo-Asensio J, Mostowy S, Harders-Westerveen J et al. PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE3, e3496 (2008).
   PubMed Web of Science ®Google Scholar